Frontiers reaches 6.4 on Journal Impact Factors

Original Research ARTICLE

Front. Cell Dev. Biol., 06 May 2015 |

Pannexin channels mediate the acquisition of myogenic commitment in C2C12 reserve cells promoted by P2 receptor activation

  • 1Departamento de Fisiología, Facultad de Ciencias Biológicas, Pontificia Universidad Católica de Chile, Santiago, Chile
  • 2Program of Anatomy and Developmental Biology, Institute of Biomedical Science, Faculty of Medicine, University of Chile, Santiago, Chile
  • 3Experimental Physiology Laboratory (EPhyL), Instituto Antofagasta, Universidad de Antofagasta, Antofagasta, Chile
  • 4Centro Interdisciplinario de Neurociencias de Valparaíso, Instituto Milenio, Universidad de Valparaíso, Valparaíso, Chile

The acquisition of myoblast commitment to the myogenic linage requires rises in intracellular free Ca2+ concentration ([Ca2+]i). Putative cell membrane pathways involved in these [Ca2+]i increments are P2 receptors (P2Rs) as well as connexin (Cx) and/or pannexin (Panx) hemichannels and channels (Cx HChs and Panx Chs), respectively, which are known to permeate Ca2+. Reserve cells (RCs) are uncommitted myoblasts obtained from differentiated C2C12 cell cultures, which acquire commitment upon replating. Regarding these cells, we found that extracellular ATP increases the [Ca2+]i via P2Rs. Moreover, ATP increases the plasma membrane permeability to small molecules and a non-selective membrane current, both of which were inhibited by Cx HCh/Panx1Ch blockers. However, RCs exposed to divalent cation-free saline solution, which is known to activate Cx HChs (but not Panx Chs), did not enhance membrane permeability, thus ruling out the possible involvement of Cx HChs. Moreover, ATP-induced membrane permeability was inhibited with blockers of P2Rs that activate Panx Chs. In addition, exogenous ATP induced the expression of myogenic commitment and increased MyoD levels, which was prevented by the inhibition of P2Rs or knockdown of Panx1 Chs. Similarly, increases in MyoD levels induced by ATP released by RCs were inhibited by Panx Ch/Cx HCh blockers. Myogenic commitment acquisition thus requires a feed-forward mechanism mediated by extracellular ATP, P2Rs, and Panx Chs.


During skeletal muscle ontogeny and regeneration, pluripotential mesodermal or satellite cells acquire myogenic commitment, which involves the expression of myogenic determination factors such as MyoD, Myf-5, and myogenin, transforming these cells into proliferative myoblasts (Charge and Rudnicki, 2004).

The acquisition of myogenic commitment requires increases in intracellular free Ca2+ concentration ([Ca2+]i), which promote the activation of calcineurin (a Ca2+-dependent protein phosphatase) that, in turn, induces the expression of the Myf5 transcription factor (Friday and Pavlath, 2001). Increases in [Ca2+]i could result from the activation of purinergic P2 receptors (P2Rs) with ATP/ADP, which are divided into two receptor families, namely ionotropic P2X and metabotropic P2Y receptors (P2YRs and P2XRs) (North, 2002; Araya et al., 2004). P2XRs are members of a family of ligand-gated non-selective cationic channels called P2X1−7 and are permeable to cations, including Na+, K+, and Ca2+ (North, 2002; Araya et al., 2004). Furthermore, the activation of P2XRs 2, 4, and 7 has been shown to increase cell membrane permeability to small molecules, including Lucifer yellow, ethidium (Etd+) and YO-PRO-1 in diverse cell types such as myoblasts and macrophages (North, 2002; Araya et al., 2004; Pelegrin and Surprenant, 2006). However, increase of plasma membrane permeability to dyes induced by P2X7R activation is absent in cells lacking pannexin1 (Panx1) expression (Pelegrin and Surprenant, 2006; Locovei et al., 2007), suggesting that channels composed of Panx1 mediate dye uptake induced by P2X7R activation. Moreover, activation of Panx1 channels (Panx1 Chs) can also be promoted via P2YRs (Locovei et al., 2006). In addition to Panxs, most cells also express connexins (Cxs), which have been shown to form connexons, also known as Cx hemichannels (Cx HChs). A connexon takes up half of a gap junction channel (GJC) and can be found on the cell surface communicating the intra and extracellular compartments (Sáez et al., 2010) just like Panx Chs do. Panx1 Chs and Cx43 HChs are permeable to Ca2+ and small molecules, including signaling molecules such as ATP (Bao et al., 2004; Vanden Abeele et al., 2006; Kang et al., 2008; Schalper et al., 2010). Diverse stimuli can increase the open probability of Cx HChs, including membrane depolarization to positive values, pro-inflammatory conditions, reduced extracellular Ca2+ concentration and rises in intracellular [Ca2+]i, among others (Sáez and Leybaert, 2014).

L6 cells constitute a cell line derived from rat myoblasts. Treating these cells with β-glycyrrhetinic acid, which blocks Cx based GJCs and HChs as well as Panx1 Chs (Schalper et al., 2008a), has been shown to inhibit the expression of myogenin and MRF4, two transcription factors that promote myogenesis and inhibits the cellular fusion process that leads to myotubes formation (Proulx et al., 1997). However, treatment with octanol, which is a blocker of Cx GJCs and HChs, but not Panx1 HChs (Bruzzone et al., 2003; Pelegrin and Surprenant, 2006), does not affect myogenesis as evaluated through the expression of the pro-myogenic transcription factor Myf5 (Proulx et al., 1997). These findings suggest that Cx GJCs and HChs are not involved in the acquisition of myogenic commitment. Accordingly, it was recently reported that Panx1 channels favor the differentiation of skeletal muscles, since inhibition of Panx1 Chs drastically reduces differentiation, whereas overexpression of Panx1 enhances muscle differentiation (Langlois et al., 2014). Muscle differentiation is a high-order process involving several steps that begin with the acquisition of myogenic commitment and the identification of the specific step affected by Panx1 Chs remains to be elucidated.

The roles of Panx1 Chs and Cx HChs in numerous biological responses in the absence of GJCs (e.g., lack of GJC expression or low density cultures that prevent GJC formation) can be distinguished by using pharmacological approaches. Panx Chs are relatively insensitive to several Cx HCh blockers, including octanol, heptanol, flufenamic acid, and La3+ (Bruzzone et al., 2003; Pelegrin and Surprenant, 2006). Moreover, Panx1 Ch activity is insensitive to reductions in extracellular [Ca2+] (Bruzzone et al., 2003; Locovei et al., 2006; Ma et al., 2009), while Cx HChs are activated in cells bathed with saline solutions containing low extracellular concentrations of divalent cations (Ca2+ and Mg2+) (Schalper et al., 2008a).

In C2C12 cell cultures, the fusion process reaches its maximum at around day 6 post-induction of differentiation. At that time, these cultures contain fused myoblasts called myotubes and undifferentiated mononuclear cells, called reserve cells (RCs), with undetectable levels of MyoD and Myf5 (Yoshida et al., 1998). In differentiated cultures containing myotubes and RCs, the extracellular activity of α-sarcoglycan, which is an ectoATPase, is also high and is likely to explain the low extracellular ATP levels present in the extracellular solution (Sandona et al., 2004). C2C12 RCs isolated by controlled trypsinization and re-plating with serum-rich medium have been shown to acquire myogenic commitment (Yoshida et al., 1998).

The present work was mainly undertaken to demonstrate the possible role of extracellular ATP, P2 receptors, Cx HChs and Panx1 Chs during the acquisition of myogenic commitment in C2C12 RCs. This molecular trilogy was found to play a critical role in skeletal muscle commitment acquisition by C2C12 RCs.

Materials and Methods


An affinity purified polyclonal anti-Panx1 serum developed in chicken was purchased from Diateva (Roma, Italy). Polyclonal antibody directed against the whole MyoD molecule was acquired from Santa Cruz Biotechnology (Santa Cruz, CA, USA), and monoclonal antibodies anti-LAP2 was purchased from Transduction Laboratories (Louisville, KY, USA). The adenosine 5′-triphosphate bioluminescence assay, ethidium bromide (Etd+), suramin, oleamide, oxidized ATP (oATP), carbenoxolone (CBX), 18 β-glycyrrhetinic acid (β-GA), FITC-conjugated goat anti-rabbit IgGs, and TRITC conjugated goat anti-mouse IgGs were obtained from Sigma (St. Louis, MO, USA). Enhanced chemiluminescence (ECL) reagents were from Pierce Biotechnology (Piscataway, NJ, USA). MRS2179 was obtained from TOCRIS (Park Elisville, MO, USA) and pyridoxalphosphate-6-azophenyl-2′,5′-disulphonate (iso-PPADS) was purchased from Cookson (Southampton, UK). Panx1 siRNA and its control (FlexiTube GeneSolution, cat n° ID: 2120593) were obtained from Qiagen (Germantown, MD, USA). Lipofectamine LTX and PLUS Reagent (cat n° 15338100) and Opti-MEM (cat n° 31985-070) were from Life Technologies (Carlsbad, CA, USA). pEGFP-N1 vector was obtained from Clontech Laboratories (Mountain View, CA, USA).

Cell Lines, Culture of C2C12 Cells, and Isolation of RCs

The C2C12 cell line derived from mouse skeletal muscle (ATCC, Manassas, VA, USA) was grown as described by Araya et al. (2004). Briefly, cells (22 × 104) were seeded on tissue culture dishes of 100-mm diameter (CORNING, Garden Glove, CA, USA) containing growth medium (GM: DMEM/F12 supplemented with 10% FBS, and 100 U/ml penicillin, 100 μg/ml streptomycin). After 3 days in GM, cell differentiation was triggered by replacing GM with differentiation medium (DM: DMEM/F12 medium supplemented with 5% horse serum, 100 U/ml of penicillin, and 100 μg/ml streptomycin). Cell cultures were fed every 48 h with DM. At day 10 of culture in DM, RCs were isolated as described by Yoshida et al. (1998). At that time period cell cultures were subjected to controlled trypsinization and released cells were seeded, 1 h after which they were washed three times and fed with GM in which RCs become myoblasts indicating acquisition of myogenic commitment (Yoshida et al., 1998).


C2C12 cells were transfected with Panx1 siRNA at final concentration of 100 nM using Lipofectamine LTX and PLUS Reagents as described for the 35 mm dish format according to the manufacturer's instructions. The transfection was performed 24 h before isolation of RCs. After 28–30 h of transfection cells were used for MyoD detection or Etd+ uptake experiments. Also the cells were transfected with pEGFP-N1 vector to control the transfection efficiency.


Electrophysiological measurements were carried out in subconfluent cell cultures plated on glass coverslips (#1) containing numerous single cells. Two hours after plating, coverlips containing cells were transferred to an experimental chamber mounted on the stage of an inverted microscope (Olympus IX-51, Olympus Optical Co, NY). For whole-cell experiments the bath solution contained (in mM) 140 NaCl, 5.4 KCl, 1 MgCl2, 1.8 CaCl2, 2 BaCl2, 10 Hepes, pH 7.4 and the pipette solution contained (in mM) 130 CsCl, 10 AspNa, 0.26 CaCl2, 1 MgCl2, 2 EGTA, 7 TEA-Cl, 5 Hepes, pH 7.2. Patch pipettes were made from borosilicate glass capillaries using a flaming/brown micropipette puller (P-87, Sutter Instruments CO, Union City, CA, USA). The tip resistance was 5–10 MΩ when filled with pipette solution. Whole-cell currents were recorded by using either voltage ramps or voltage steps increasing in 20 mV from −80 to +80 mV, as described previously (Schalper et al., 2008b). Currents were filtered at 1 kHz and sampled at 5 kHz. Then, records were filtered with a digital low-pass filter of 0.5 kHz. Data acquisition and analysis were performed with pClamp 9 (Axon Instruments, Novato, CA, USA).

Dye Uptake and [Ca2+]i Measurements

For dye uptake measurements, RCs were plated onto glass coverslips and after 2 h they were washed twice with Krebs–Ringer buffered saline solution (in mM: 145 NaCl, 5 KCl, 1 CaCl2, 1 MgCl2, 5.6 glucose, 10 HEPES-Na, pH 7.4) containing 5 μM Etd+, and fluorescence was recorded at regions of interest in different cells with a water immersion Olympus 51W1I upright microscope. Images were captured with a Q Imaging model Retiga 13001 fast-cooled monochromatic digital camera (12-bit) (Qimaging, Burnaby, BC, Canada) every 30 s (exposure time = 30 ms, gain = 0.5) and image processing was performed off-line with ImageJ software (NIH, Bethesda, USA).

The Ca2+/Mg2+-free saline contained (in mM) 145 NaCl, 5 KCl, 0.5 EGTA, 5.6 glucose, 10 HEPES-Na, pH 7.4. Cells seeded on glass coverslips were placed in a 1 ml chamber located on the stage of an inverted microscope equipped with epifluorescence illumination (Olympus T041, New Hyde Park, NY, USA), where recordings were performed. After excitation with a 488-nm wavelength with a Xenon arc lamp and filter system, the fluorescence sequences of 80 images were collected every 4.5 s at 200-ms exposure. Data were acquired with a CCD cooled camera (MCD600, Spectra Source Instruments, West lake Village, CA, USA) connected to a microscope side port; the full or partial image acquisition was computer-controlled through macros that operate the software provided by the manufacturer. Image processing was done off-line with the public domain ImageJ software. The collected data were illustrated as folds of basal fluorescence vs. the difference of initial fluorescence and fluorescence at the time of interest (ΔF/F0) - (ΔF/F0)b, corrected with respect to basal fluorescence in order to reduce the photo bleaching artifact of Fluo-3.

Western Blot and Indirect Immunofluorescence Analysis

Cells were washed twice with ice-cold PBS (pH 7.4) and then harvested by scraping with a rubber policeman in 1 ml lysis buffer (PBS containing protease inhibitors: 2 mM phenylmethylsulfonyl fluoride, 200 μg soybean trypsin protease inhibitor, 1 mg/ml benzamidine, 1 mg/ml ε-aminocaproic acid, and 500 μg/ml leupeptin, and phosphatase inhibitors: 20 mM Na4P207 and 100 mM NaF) and then sonicated. Western blot analyses were performed as described previously (Schalper et al., 2008b). Blots were incubated overnight with polyclonal rabbit immunopurified anti-MyoD antibodies diluted with 5% non-fat milk in PBS. Then, they were rinsed with PBS and incubated for 1 h at room temperature with horse radish peroxidase-conjugated goat anti-rabbit IgG antibodies at appropriated dilution in PBS with 5% non-fat milk in PBS. After repeated rinses, immunoreactive proteins were detected using ECL reagents (Pierce biotechnology, Rockford, IL) according to the manufacturer's instructions.

Cells grown on glass coverslips were washed three times with PBS, pH 7.4, fixed with 4% formaldehyde for 5 min at room temperature and then incubated in blocking solution (PBS–1% BSA, pH 7.4) for 30 min at room temperature. Samples were incubated overnight at 4°C with appropriately diluted rabbit anti-MyoD antibody. Then, samples were processed as previously described (Araya et al., 2004). Immunoreactive sites were detected with FITC-conjugated goat anti-rabbit IgG secondary antibodies. Cells were rinsed and mounted with fluoromount G (Electron Microscopy Sciences, Hatfield, PA, USA) on glass slides and observed under a Nikon Labophot-2 microscope equipped with epifluorescent illumination and photographed. Immunolocalization of MyoD was carried out in coverslips and mounted in Vectashield (Vector Laboratories) for confocal microscopy and representative images were acquired (Carl Zeiss Axiovert 135, LSM Microsystems). Only secondary antibodies were added for negative controls.

Data Analysis and Statistics

For each data group, results are expressed as mean ± SEM, and n refers to the number of independent experiments. For statistical analysis, each treatment was compared to its respective control, and significance was determined by using a One-Way ANOVA followed by a Tukey post-hoc test. Differences were considered significant at p < 0.05. Statistics were performed with Microsoft Excel (2007) and Graph Pad Prism 4 (2003).


Extracellular ATP Activates Ca2+ Signal in Uncommitted RCs via Purinergic Receptors and Panx Channels

In other cell types, extracellular ATP increases the [Ca2+]i through activation of P2X or P2Y receptors (Illes and Alexandre Ribeiro, 2004). Moreover, activation of P2Rs has been demonstrated to be required for skeletal muscle terminal differentiation (Araya et al., 2004). Here, we evaluated whether P2Rs are present and participate in commitment acquisition, which is an earlier stage of skeletal muscle ontogeny. To address this issue, uncommitted RCs (Yoshida et al., 1998) were obtained from differentiated cultures of C2C12 cells. They were loaded with the free Ca2+ indicator Fluo-3 and stimulated with a bath application of ATP, while the (ΔF/F0) - (ΔF/F0)b (hereinafter called Ca2+ signal) was monitored.

After the application of 150 μM ATP, the Ca2+ signal in all cells remained unchanged for a brief period of time (<10 s) and then showed a rapid increase followed by a plateau phase well-above the basal value (Figure 1A). To determine the contribution of P2Rs, RCs were pretreated for 5 min with 200 μM suramin, which is a concentration that blocks P2XRs and P2YRs, and then treated with 150 μM ATP, resulting in absence of Ca2+ signal response (Figure 1A). Then, the possible contribution of ionotropic P2XRs and metabotropic P2Y1R in the Ca2+ signal triggered by ATP was evaluated. Cells were pre-treated for 5 min with 100 μM iso-PPDAS, a general P2XR blocker (Araya et al., 2004) or 10 μM MRS2179, a specific P2Y1R blocker (Baurand and Gachet, 2003). The inhibition of P2XRs drastically reduced the amplitude and raise phase of the transient Ca2+ signal peak; the response showed only ~34% amplitude and ~24% area under the curve as compared to control (Figure 1B), while these two parameters were not significantly affected by P2Y1R inhibition (Figure 1B). Notably, the plateau phase that followed the transient peak of Ca2+ signal promoted by extracellular 150 μM ATP was completely abrogated by the inhibition of P2XRs or P2Y1Rs (Figure 1B), suggesting that iso-PPDAS-sensitive P2XRs and MRS2179-sensitive P2Y1Rs are partially responsible for activating the mechanism that drives the plateau phase of the Ca2+ signal. In cells pretreated with 150 μM oATP, another P2XR blocker, the Ca2+ signal elicited by 150 μM ATP was comparable to that of cells pretreated with iso-PPDAS (not shown).


Figure 1. Activation of P2Rs with extracellular ATP elevates intracellular Ca2+ levels in C2C12 RCs. Time course of relative fluorescence changes induced by bath application of 150 μM ATP (arrow) in C2C12 RCs loaded with Fluo-3. (A) Cells were stimulated with 150 μM ATP alone or preincubated (5 min) with 200 μM suramin (a P2Y and P2X receptor antagonist) and then treated with ATP. (B) RCs were preincubated (5 min) with 10 μM MRS2179 or 100 μM iso-PPADS followed by stimulation with 150 μM ATP. (C) RCs preincubated (5 min) with 10Panx1 peptide or 10 μM carbenoxolone (CBX) and then stimulated with ATP. Each point corresponds to the mean ± SEM, n = 3 experiments. At least 10 cells were recorded per experiment.

In order to study the possible involvement of Panx1 Chs in Ca2+ signaling promoted by extracellular 150 μM ATP, RCs were first treated for 5 min with 200 μM 10Panx1 peptide or 10 μM carbenoxolone, which are two Panx1 Ch blockers (Bruzzone et al., 2005; Pelegrin and Surprenant, 2006). Under these conditions, the Ca2+ signal elicited by RCs was fast and transient but was not followed by a persistent plateau phase (Figure 1C), suggesting a critical involvement of Panx1 Chs in the establishment of this feature of the ATP-promoted Ca2+ signal in RCs.

RCs Present Membrane Panx Channels Activated by Extracellular ATP

Extracellular ATP also increases membrane permeability to small molecules mainly through activation of Panx1 Chs (Locovei et al., 2006; Pelegrin and Surprenant, 2006; Nishida et al., 2008). In the present study, ATP increased [Ca2+]i in C2C12 RCs (Figure 1), but it remained unknown whether RCs exhibit active Cx HChs or Panx Chs at the cell surface.

To demonstrate the presence of Panx Chs activated by extracellular ATP via P2Rs in C2C12RCs, we evaluated changes in membrane permeability to Etd+, which has been used as a permeability probe in time lapse measurements (Schalper et al., 2008a,b). Treatment with 150 μM ATP for 15 min induced a heterogeneous Etd+ uptake response of RCs (Figure 2Aa). To determine if the ATP-induced response was mediated by P2XRs, RCs were simultaneously treated for 15 min with 150 μM oATP and 150 μM ATP. Under this condition, no Etd+ uptake was detected in ~90% of the cells (Figure 2Ac). Then, the ATP-induced Etd+ uptake was quantified over time. Etd+ uptake was very low during the first 2–4 min of recording under control conditions (Figures 2B,C). However, at about 4 min after treatment with 150 μM ATP, a rapid increase in Etd+ uptake occurred (Figures 2B,C) and either the acute application of 150 μM oATP (Figures 2B,D) or 100 μM oleamide (Figures 2C,D) drastically reduced Etd+ uptake, thus reaching values close to those measured under control conditions. Treatment of RCs with 150 μM ATP induced Etd+ uptake as described above and the acute application of selective a P2Y1R (MRS2179) (Baurand and Gachet, 2003), P2XRs (iso-PPADS) or P2X7R (A740003) (Honore et al., 2006) blocker drastically reduced Etd+ uptake (Figure 2E), suggesting that simultaneous ATP-induced activation of P2Y and P2X receptors would be required for opening of Panx1 Chs in RCs. Moreover, we tested whether P2Y1R and P2X7R blockers affect the activity of open Panx1 Chs. To this end, HeLa cells transfected with Panx1 were mechanically stressed with eight drops of saline solution falling from about 10 cm high to induce Panx1 Ch opening. During recordings of Etd+ uptake, cells were treated with MRS2179, iso-PPADS or A740003, which did not affect the Etd+ uptake rate (Figure 2E), indicating that these compounds do not block Panx1 Chs.


Figure 2. C2C12 RCs express functional P2X receptors and pannexin channels. C2C12 RCs seeded onto glass cover slips were maintained for 1 h in growth medium so they could attach. Then, cells were washed three times and after 0.5 h they were exposed to Krebs–Ringer saline solution containing 5 μM Ethidium (Etd+). Thereafter, cells were treated with 150 μM ATP and Etd+ uptake was evaluated. (Aa) Microphotograph taken 15 min after 150 μM ATP application. (Ac) co-application of 150 μM oATP blocked dye uptake induced by 150 μM ATP. (Ab, Ad) Phase contrast views of fields shown in Aa and Ac, respectively. (B) Time-lapse measurements of Etd+ uptake in several cells (8 in B and 14 in C) under control conditions (5 or 2 min, respectively) and after the application of 150 μM ATP (B, C), indicated with the arrow. After 10 or 8 min of recording under control conditions 150 μM oATP (B) or 100 μM oleamide (C) was applied (arrow). In (B), the continuous line represents the mean ± SEM of three experiments in cells treated only with ATP. (D) Bar graph showing the Etd+ uptake rate of cells treated as in (B) and (C). Each number corresponds to the average ± SEM (n = 3 experiments); 8–15 cells were recorded per experiment. In addition, cells were exposed to saline solution without Ca2+ and Mg2+ (DCFS), known to induce Cx HC opening. (E) Etd+ uptake rate in RCs treated with ATP or in HeLa-Panx1 cells treated with mechanical stress (M.S.) to induce opening of Panx1 channels. In both cell types the effect of blockade of P2Y1R (30 μM MRS2179), P2XRs (50 μM iso-PPADS) or P2X7R (10 μM A740003) on the Etd+ uptake rate was evaluated. ***p < 0.001.

Divalent cation free solution (DCFS), known to increase the open probability of Cx HChs, did not promote Etd+ uptake in RCs (Figure 2D), suggesting that Cx HChs are not involved in ATP induced Etd+ uptake.

To further demonstrate the presence of Panx Chs in cell membranes of RCs, we characterized the membrane current responses induced by transmembrane voltages under resting conditions and after applying extracellular ATP in the absence and presence of Cx HCh/Panx1 Ch blockers, which only blocked Panx Chs in this preparation because we did not detect Cx HChs (see above).

Two hours after plating, total RC membrane current was evaluated by means of whole-cell patch clamp and applying voltage steps (~4 s and 20 mV changes) or ramps between −80 and +80 mV of 5 s duration. Under this condition, the membrane currents generated at all voltages were very small (Figures 3A–C) and increased linearly passing through zero at 0 mV (Figures 3B,C). In less than 10 s treatment with 150 μM ATP, the currents generated with different voltage commands were much more robust and the I/V curves showed an increase in total current as compared to control conditions (Figures 3A–C). In addition, after treatment with 100 μM oleamide (Figures 3A,B) or 50 μM β-GA (Figure 3C) total current drastically decreased to values close to or even below those recorded under basal conditions.


Figure 3. Extracellular ATP enhances the membrane current mediated by Panx1 channels. Representative I/V curve of total membrane current recorded in freshly seeded RCs evaluated under voltage clamp by using the whole cell patch clamp configuration. Rectangular voltage steps or voltage ramp between −80 and +80 mV were applied during ~4 or 20 s, respectively. (A) Top traces correspond to the protocol of voltage commands (Vm) applied and the other traces correspond to a representative set of currents recorded under control conditions, after treatment with 300 μM ATP or simultaneous treatment with 100 μM oleamide and 300 μM ATP. (B,C) The membrane current promoted by voltage ramp under resting conditions (Basal), followed by the application of 150 μM ATP and then, the application of (A) 100 μM oleamide or (B) 50 μM β-GA. (D) Bar graph showing the percentage with respect to control conditions of the slope of membrane currents, in the presence (+) or absence (–) of ATP, 100 μM oleamide, 50 μM β-GA as described above or 150 μM oATP in the absence or presence of 150 μM ATP. The digit above each bar indicates the number of experiments.

After 150 μM ATP treatment, the slope of the membrane current trace was 617 ± 207% above that of control conditions (Figure 3D). In the same RC treatment the application of 100 μM oleamide reduced ATP-induced current to 224 ± 86% above control conditions (Figure 3D). Similarly and in separate experiments, the slope of the ATP-induced membrane current was reduced to 172 ± 71% above control conditions in RCs treated with 50 μM β-GA (Figure 3D). Surprisingly, the application of 150 μM oATP, which is a P2XR blocker (Araya et al., 2004), reduced the current slope to 50 ± 1% below that of RCs under control conditions (not treated with ATP) (Figure 3D), suggesting the involvement of functional P2XRs under basal activations. Moreover, the application of 150 μM oATP immediately reduced the slope of the ATP-induced current to 53 ± 2% below control values (Figure 3D).

Acquisition of Myogenic Commitment Requires Activation of P2X Receptors and Functional Panx1 Channels

MyoD levels increase in C2C12 RCs cultured in GM, hence revealing the acquisition of myogenic commitment (Yoshida et al., 1998). To determine the role of P2Rs in this process, immunofluorescence and Western blot analyses of MyoD in RCs treated with different P2R and Panx1 Ch inhibitors were performed (Figure 4). Since primary cultures of RCs were contaminated with differentiated myotubes that express MyoD, the possible role of P2 receptors on MyoD expression by RCs was first evaluated by immunofluorescence detection in isolated mononuclear cells at different time periods after plating. MyoD was not detected in any of the mononuclear cells at 0.5 h after plating, indicating that they were uncommitted RCs (Figure 4Aa). However, after 24 h all RCs showed MyoD reactivity (Figures 4Ab,Ag) and the increased expression of MyoD was completely prevented in all RCs bathed in GM containing 150 μM oATP (Figure 4Ac), 200 μM 10Panx1 (Figure 4Ah) or 1 mM probenecid (Figure 4Ai).


Figure 4. C2C12 RCs require functional P2X receptors and Panx1 channels for myogenic commitment acquisition. (A) Immunofluorescence detection of MyoD in C2C12 RCs cultured for 0.5 h (Aa) and 24 h in (Ab) the absence or (Ac) presence of 150 mM oATP. Ad–Af are contrast phase views of fluorescent fields shown in Aa–Ac, respectively. Bar = 20 nm. Ag–Ai show the presence of MyoD (green) in nuclei, marked by LAP2 (red), a nuclear membrane marker, at 24 h of RC cultures, in normal (Ag), siPanx1 (Ah), and probenecid (Ai, 1 mM) treated cells. (B) Two consolidates of at least three Western blot analyses of C2C12 RCs under control conditions (24 h) or after treatment for 24 h with 300 μM ATP, 150 μM oATP, 30 μM MRS2179, 200 μM brilliant blue G (BBG), 50 μM iso-PPADS, 200 μM suramin or HC blockers added simultaneously: 50 μM b-GA, 100 μM oleamide in the absence or presence of 300 μM ATP. All values were normalized to the control value of each experiment. *p < 0.05 and **p < 0.01.

As seen through Western blot analyses, MyoD levels in cells treated with 300 μM ATP were ~2.5 fold higher than in control cells (basal MyoD levels found in total cell homogenates could be explained by the contaminating myotubes mentioned above and were considered as basal levels in normalization). Additionally, MyoD levels in RC cultures treated with 300 μM oATP were even lower than in control cultures (Figure 4B). Since the P2XR blocker drastically reduced ATP-induced dye uptake (Figure 2B), it was possible to infer that oATP blocked ATP release, and thus, the extracellular ATP concentration necessary to effectively activate P2Rs was not attained. To test this possibility, RCs were treated simultaneously with 300 μM oATP and exogenous 300 μM ATP. Under these conditions, the effect of oATP predominated over the effect of endogenous ATP (Figure 4B), indicating the absolute requirement of functional P2XRs in order to transduce the action of extracellular ATP in controlling MyoD levels. Since ATP can be released to the extracellular milieu through Panx1 Chs, the effects of oleamide and β-GA (two Panx1 Ch blockers) were tested in relation to increases in MyoD levels induced by exogenous ATP. MyoD levels in RCs treated with 100 μM oleamide or 50 μM β-GA were lower than in control cells (Figure 4B), suggesting that Panx Chs play a relevant role in this process. However, the presence of Panx Ch blockers did not significantly affect the increase in MyoD levels induced by exogenous ATP (Figure 4B), suggesting that the release of endogenous ATP via Panx Chs was overcame by the added ATP. Moreover, inhibition of P2Y1R (MRS2179), Panx1 Chs (oleamide), P2Xs and Panx1 Chs (BBG), P2XRs (iso-PPADS or oATP) and P2YRs/P2XRs (suramin) reduced MyoD levels to values below those found in RCs cultured in GM (Figure 4B).

To further demonstrate the importance of Panx1 Chs in myogenesis, we studied whether Panx1 turndown affects MyoD activation by using immunofluorescence and confocal microscopy. After 48 h of induced the acquisition of myogenic commitment with GM, all control cells presented MyoD reactivity in the nucleus underlined with Lap2, which is a nuclear membrane marker (Figure 5A). However, ~75% of the cells transfected with siRNA for Panx1 did not present MyoD reactivity in the nucleus (Figure 5A). The efficiency of transfection was tested with the same transfection protocol and a vector carrying the cDNA for a fluorescent protein (pEGFP) corresponded to ~75% (not shown). In addition, ATP-induced Etd+ uptake of cells transfected with siRNA for Panx1 was drastically reduced as compared to untransfected cells (Figure 5B).


Figure 5. Panx1 is required for ATP-induced myogenic commitment of RCs. Reserve cells (RCs) were isolated from 7 days in differentiated C2C12 cultures and placed on cover slips. For siPanx1 experiments, C2C12 differentiated cultures were transfected with siPanx1 in lipofectamine solution at 24 h before isolation of RCs. After 24 h of isolation of RCs (48 h of siPanx1 transfection) Panx1 reactivity (Green, top panels) was reduced (Top right) as compared to control condition (top left). The MyoD nuclear distribution was analyzed (A, green) by co-immunofluorescence with LAP2 (red signal), which is a nuclear membrane marker. In parallel experiments, hemichannel activity was monitored in ethidium (Etd+) uptake assays (B), where Etd+ uptake was induced with ATP (150 μM) and inhibited with oleamide (100 μM).

Acquisition of Myogenic Commitment Occurs in the Absence of Connexin Gap Junctions

Since gap junction channels have been proposed to play a relevant role in the late stages of myogenic differentiation (Araya et al., 2004), we decided to study whether gap junctional communication is required for an early steps such as toward the myogenic commitment response. This possibility was tested in RCs cultured in low density to avoid the formation of cell–cell contacts where gap junction channels can be formed. Under these conditions, mononucleated cells without physical contact with neighboring cells cultured for 24 in GM medium presented MyoD reactivity in the nucleus (Figures 6A,B). In contrast, cells cultured in GM containing 100 μM oleamide (to block Panx1 Chs) did not present MyoD reactivity (Figures 6C,D).


Figure 6. Panx1 channels, but not gap junction channels, are needed for myogenic commitment acquisition of RCs. Sparse reserve cells (RCs), to avoid gap junction formation, were cultured under control conditions (A) or in the presence of 100 μM oleamide (C), which is a Panx1 channel blocker. After 24 h of culture, cells were fixed and processed for MyoD detection by immunofluorescence. Panels (B) and (D) are phase contrast views of the fluorescent fields shown in (A) and (C), respectively.


In this report, we observed that extracellular ATP increases the Ca2+ signal via P2Rs as well as membrane current and permeability to Etd+ mediated by Panx1 Chs and expression levels of MyoD in C2C12 RCs. Moreover, we showed that RCs do not express functional Cx HChs on their surface, but express Panx1 Chs that possibly serve to release ATP to the extracellular milieu. Therefore, we propose that the acquisition of myogenic commitment in RCs requires a feed forward mechanism that includes Panx Ch-dependent ATP release and activation of P2Rs.

We found that only a few seconds (<10 s) after ATP application RCs showed a rise in Ca2+ signal and an increase in total membrane current sensitive to Cx HCh/Panx Ch blockers. The rapid and transient rise in Ca2+ signal was mediated by P2Y and P2X receptors, since it was only partly prevented by the inhibition of P2XRs with iso-PPDAS and oATP (two P2XR blockers) or MRS2179 (P2Y1R blocker), and was completely prevented by suramin, which is a non-selective blocker of both P2YRs and P2XRs (Illes and Alexandre Ribeiro, 2004). On the other hand, the late increase in Ca2+ levels induced by ATP was not prevented by either of the two P2 receptor blockers used, but further studies would be required to elucidate the mechanism involved. Moreover, freshly seeded RCs treated with ATP showed a rapid (<10 s) increase in total membrane current mediated by Panx Chs, since it was reduced by oleamide and β-GA and Cx HCh activity was not detected in DCFS. This is in agreement with previous results indicating that octanol, a Cx based channel blocker, does not affect myogenesis (Proulx et al., 1997). However, Cx43-based channels have been observed in transgenic mice with an inducible CRE-lox (p) system to abrogate the expression of Cx43flox/flox (Araya et al., 2003, 2005). In this system, the regeneration of skeletal muscle after injury is delayed with respect to wild type animals by about 14 days, suggesting that myoblasts require cellular coordination via Cx43 membrane channels for a normal timing of regeneration.

A fraction of the ATP-induced membrane current appears to be mediated by P2XRs, since the current slope was smaller in RCs treated with oATP alone than in RCs under resting conditions. Moreover, an important part of the ATP-induced current increase (>63%) was mediated by HCs, since both oleamide and β-GA reduced the total membrane current slope to a value about twice of that recorded in control cells and three times lower than that measured after treatment with ATP alone. Similar activation of Panx Chs via P2XRs has been demonstrated in other cell types (Locovei et al., 2006, 2007; Pelegrin and Surprenant, 2006). P2XRs belong to an ionotropic membrane receptor family (North, 2002). If P2X7Rs were the only P2XRs expressed by RCs, the heterogeneity of the Etd+ uptake response elicited by ATP might be explained by the heterogeneous P2X7R abundance. Moreover, the P2YR type expressed by RCs is likely to be P2Y1R, since MRS2179, which is a selective P2Y1R blocker (Baurand and Gachet, 2003), reduced or inhibited several RC responses described herein.

With regard to the possible molecular composition of HCs involved in both ATP-induced increases in membrane current and membrane permeability to Etd+, RCs did not express functional Cx HChs as indicated by the lack of dye uptake after exposure to DCFS, which is known to activate Cx HChs and not Panx Chs (Schalper et al., 2008a; Ma et al., 2009). An alternative explanation for the inhibitory effect of Cx HCh blockers on the effects of ATP described herein would be the existence of Panx Chs. Whether RCs express other members of the Panx family remains unknown, and therefore, demonstration of monomeric or heteromeric Panx Chs in RCs would require further investigation.

Previous studies have demonstrated the autocrine/paracrine role of ATP during skeletal muscle differentiation (Ryten et al., 2002; Araya et al., 2004) and ATP release through Panx1 Chs was shown to elicit Ca2+ signals involved in gene expression in rat myotubes (Buvinic et al., 2009). The present study found that RCs release ATP to the extracellular milieu, which most likely occurred via Panx1 Chs because channel blockers or the Panx1 knockdown drastically reduced the acquisition of myogenic commitment.

During skeletal muscle embryogenesis, somites express transcription factors that control different processes, including migration and myogenic transcription factors that regulate terminal differentiation such as MyoD, Myf-5, and myogenin (Charge and Rudnicki, 2004). Moreover, the role of P2X receptors play a role in proliferation and/or differentiation of skeletal muscles (Burnstock et al., 2013). In agreement with this interpretation, blockade of P2XRs with oATP, even when co-added with ATP, prevented the increase of MyoD levels, suggesting that it is required for the acquisition of myogenic commitment. In line with this notion, oleamide and β-GA prevented the rise of MyoD levels. However, this inhibition was totally reversed with the addition of ATP, showing that these Cx HCh/Panx Ch blockers are not toxic and do not block purinergic pathways.

The results described in the present work might contribute to explaining findings in other preparations. For instance, treatment of primary myoblasts with α-GA inhibits the increase of MyoD and increases levels of adiposity markers PPARγ and C/EBPα, both of which are transcription factors required for adipose differentiation (Yamanouchi et al., 2007), suggesting that Cx and/or Panx HCs play relevant roles during those events. In support of this possibility, Panx3 has been proposed to form GJCs between osteoblasts and to contribute to the differentiation of C2C12 cells into osteoblasts (Ishikawa et al., 2011).

Despite the absence of Panx1 in knockout mice, these animals have no apparent phenotype due to deficient skeletal muscle myogenesis. A possible explanation might be that in absence of Panx1 (a Ca2+ channel) myocytes express other Ca2+-permeable channel as a compensatory mechanism. In this sense, it has been established that a compensatory increase of P2X7R (i.e., a Ca2+ channel) expression occurs in lymphocytes from Panx1 knockout mice (Shoji et al., 2014), which also might occur in skeletal muscles. However, there are still some physiological issues regarding skeletal muscles from Panx1 knockout animals. For instance, these muscles do not produce potentiation of muscular contraction (Riquelme et al., 2013). Furthermore, additional problems in these mice have been published, such as uncompleted abolishment (70%) of Panx1 mRNA in some tissues like trigeminal ganglia, bladder and spleen (Hanstein et al., 2013). Additionally, it has been established in different systems that Panx1 Ch activation requires functional P2X or P2YR upstream Panx1 Ch activation, but in this case it was necessary to simultaneously stimulate both P2 receptor types, which could be explained by two manners of Panx1 Ch activation. The first one is mediated by activation of Ca2+ inflow from the extracellular space through P2XRs and the other is mediated by G-protein signaling and Ca2+ from intracellular stores induced by P2YR activation. This possibility implies that activation of both P2 receptors leads to an optimal [Ca2+]i for Panx1 HC activation, but neither P2XR nor P2Y1R alone would be sufficient.

Finally, we propose that purinergic P2Rs and Panx1 Chs are part of a positive feedback system present in C2C12 RCs. Activation of P2XRs by extracellular ATP, released through Panx Chs activated via P2Rs. Moreover, activated P2XRs and Panx Chs are permeable to Ca2+ (Vanden Abeele et al., 2006) and, thus, they might contribute to the rises in Ca2+ signals observed in ATP-treated RCs. As a result of the latter, Panx1 Chs could be activated via a cytoplasmic factor (i.e., PKC and/or calmodulin/Ca2+-dependent kinase) (Barbe et al., 2006), allowing for more ATP release. The positive loop may be inhibited in differentiated cultures of C2C12, which could provide a possible explication for the reduction of MyoD levels in mononucleated cells, since the extracellular medium is known to contain high levels of phosphatase activity (Sandona et al., 2004). The latter is directly related to the expression of α-sarcoglycan, which is a proteoglycan with ATP binding domains and phosphatase activity (Sandona et al., 2004). In this way, both the ATP tone and MyoD levels could be diminished. In support of this putative mechanism, replated RCs with low levels of myotube contamination, and consequently, low levels of phosphatases, would allow for ATP accumulation in the extracellular medium, which would induce the acquisition of myogenic commitment.

Conflict of Interest Statement

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.


The authors have no conflicting financial interests. This work was partially supported by Fondo Nacional de Desarrollo Científico y Tecnológico (FONDECYT-1111033 and -1150291 to JCS and 11130013 to JLV), ICM-Economía P09-022-F Centro Interdisciplinario de Neurociencias de Valparaíso (to JS) and the Doctoral thesis support fellowship AT 23070155 to MR. The data of this paper are form a thesis submitted in partial fulfillment of the requirements for the degree of Doctor in Physiological Sciences (MR) at the Pontificia Universidad Católica de Chile.


Araya, R., Eckardt, D., Maxeiner, S., Kruger, O., Theis, M., Willecke, K., et al. (2005). Expression of connexins during differentiation and regeneration of skeletal muscle: functional relevance of connexin43. J. Cell. Sci. 118, 27–37. doi: 10.1242/jcs.01553

PubMed Abstract | Full Text | CrossRef Full Text | Google Scholar

Araya, R., Eckardt, D., Riquelme, M. A., Willecke, K., and Sáez, J. C. (2003). Presence and importance of connexin43 during myogenesis. Cell. Commun. Adhes. 10, 451–456. doi: 10.1080/cac.10.4-6.451.456

PubMed Abstract | Full Text | CrossRef Full Text | Google Scholar

Araya, R., Riquelme, M. A., Brandan, E., and Sáez, J. C. (2004). The formation of skeletal muscle myotubes requires functional membrane receptors activated by extracellular ATP. Brain. Res. Brain Res. Rev. 47, 174–188. doi: 10.1016/j.brainresrev.2004.06.003

PubMed Abstract | Full Text | CrossRef Full Text | Google Scholar

Bao, L., Locovei, S., and Dahl, G. (2004). Pannexin membrane channels are mechanosensitive conduits for ATP. FEBS Lett. 572, 65–68. doi: 10.1016/j.febslet.2004.07.009

PubMed Abstract | Full Text | CrossRef Full Text | Google Scholar

Barbe, M. T., Monyer, H., and Bruzzone, R. (2006). Cell-cell communication beyond connexins: the pannexin channels. Physiology 21, 103–114. doi: 10.1152/physiol.00048.2005

PubMed Abstract | Full Text | CrossRef Full Text | Google Scholar

Baurand, A., and Gachet, C. (2003). The P2Y1 receptor as a target for new antithrombotic drugs: a review of the P.2Y1 antagonist MRS-2179. Cardiovasc. Drug Rev. 21, 67–76. doi: 10.1111/j.1527-3466.2003.tb00106.x

PubMed Abstract | Full Text | CrossRef Full Text | Google Scholar

Bruzzone, R., Barbe, M. T., Jakob, N. J., and Monyer, H. (2005). Pharmacological properties of homomeric and heteromeric pannexin hemichannels expressed in Xenopus oocytes. J. Neurochem. 92, 1033–1043. doi: 10.1111/j.1471-4159.2004.02947.x

PubMed Abstract | Full Text | CrossRef Full Text | Google Scholar

Bruzzone, R., Hormuzdi, S. G., Barbe, M. T., Herb, A., and Monyer, H. (2003). Pannexins, a family of gap junction proteins expressed in brain. Proc. Natl. Acad. Sci. U.S.A. 100, 13644–13649. doi: 10.1073/pnas.2233464100

PubMed Abstract | Full Text | CrossRef Full Text | Google Scholar

Burnstock, G., Arnett, T. R., and Orriss, I. R. (2013). Purinergic signalling in the musculoskeletal system. Purinergic Signal. 9, 541–572. doi: 10.1007/s11302-013-9381-4

PubMed Abstract | Full Text | CrossRef Full Text | Google Scholar

Buvinic, S., Almarza, G., Bustamante, M., Casas, M., López, J., Riquelme, M., et al. (2009). ATP released by electrical stimuli elicits calcium transients and gene expression in skeletal muscle. J. Biol. Chem. 284, 34490–34505. doi: 10.1074/jbc.M109.057315

PubMed Abstract | Full Text | CrossRef Full Text | Google Scholar

Charge, S. B., and Rudnicki, M. A. (2004). Cellular and molecular regulation of muscle regeneration. Physiol. Rev. 84, 209–238. doi: 10.1152/physrev.00019.2003

PubMed Abstract | Full Text | CrossRef Full Text | Google Scholar

Friday, B. B., and Pavlath, G. K. (2001). A calcineurin- and NFAT-dependent pathway regulates Myf5 gene expression in skeletal muscle reserve cells. J. Cell. Sci. 114, 303–310.

PubMed Abstract | Full Text | Google Scholar

Hanstein, R., Negoro, H., Patel, N. K., Charollais, A., Meda, P., Spray, D. C., et al. (2013). Promises and pitfalls of a Pannexin1 transgenic mouse line. Front. Pharmacol. 4:61. doi: 10.3389/fphar.2013.00061

PubMed Abstract | Full Text | CrossRef Full Text | Google Scholar

Honore, P., Donnelly-Roberts, D., Namovic, M. T., Hsieh, G., Zhu, C. Z., Mikusa, J. P., et al. (2006). A-740003 [N-(1-[cyanoimino)(5-quinolinylamino) methyl] amino-2,2-dimethylpropyl)-2-(3,4-dimethoxyphenyl)acetamide], a novel and selective P2X7 receptor antagonist, dose-dependent reduces neuropathic pain in the rat. J. Pharmacol. Exp. Ther. 319, 1376–1385. doi: 10.1124/jpet.106.111559

PubMed Abstract | Full Text | CrossRef Full Text | Google Scholar

Illes, P., and Alexandre Ribeiro, J. (2004). Molecular physiology of P2 receptors in the central nervous system. Eur. J. Pharmacol. 483, 5–17. doi: 10.1016/j.ejphar.2003.10.030

PubMed Abstract | Full Text | CrossRef Full Text | Google Scholar

Ishikawa, M., Iwamoto, T., Nakamura, T., Doyle, A., Fukumoto, S., and Yamada, Y. (2011). Pannexin 3 functions as an ER Ca2+ channel, hemichannel, and gap junction to promote osteoblast differentiation. J. Cell. Biol. 193, 1257–1274. doi: 10.1083/jcb.201101050

PubMed Abstract | Full Text | CrossRef Full Text | Google Scholar

Kang, J., Kang, N., Lovatt, D., Torres, A., Zhao, Z., Lin, J., et al. (2008). Connexin 43 hemichannels are permeable to ATP. J. Neurosci. 28, 4702–4711. doi: 10.1523/JNEUROSCI.5048-07.2008

PubMed Abstract | Full Text | CrossRef Full Text | Google Scholar

Langlois, S., Xiang, X., Young, K., Cowan, B. J., Penuela, S., and Cowan, K. N. (2014). Pannexin 1 and pannexin 3 channels regulate skeletal muscle myoblast proliferation and differentiation. J. Biol. Chem. 289, 30717–30731. doi: 10.1074/jbc.M114.572131

PubMed Abstract | Full Text | CrossRef Full Text | Google Scholar

Locovei, S., Scemes, E., Qiu, F., Spray, D. C., and Dahl, G. (2007). Pannexin1 is part of the pore forming unit of the P2X7 receptor death complex. FEBS Lett. 581, 483–488. doi: 10.1016/j.febslet.2006.12.056

PubMed Abstract | Full Text | CrossRef Full Text | Google Scholar

Locovei, S., Wang, J., and Dahl, G. (2006). Activation of pannexin 1 channels by ATP through P2Y receptors and by cytoplasmic calcium. FEBS Lett. 580, 239–244. doi: 10.1016/j.febslet.2005.12.004

PubMed Abstract | Full Text | CrossRef Full Text | Google Scholar

Ma, W., Hui, H., Pelegrin, P., and Surprenant, A. (2009). Pharmacological characterization of pannexin-1 currents expressed in mammalian cells. J. Pharmacol. Exp. Ther. 328, 409–418. doi: 10.1124/jpet.108.146365

PubMed Abstract | Full Text | CrossRef Full Text | Google Scholar

Nishida, M., Sato, Y., Uemura, A., Narita, Y., Tozaki-Saitoh, H., and Nakaya, M. (2008). P2Y6 receptor-Galpha12/13 signalling in cardiomyocytes triggers pressure overload-induced cardiac fibrosis. EMBO. J. 27, 3104–3115. doi: 10.1038/emboj.2008.237

PubMed Abstract | Full Text | CrossRef Full Text | Google Scholar

North, R. A. (2002). Molecular physiology of P2X receptors. Physiol. Rev. 82, 1013–1067. doi: 10.1152/physrev.00015.2002

PubMed Abstract | Full Text | CrossRef Full Text | Google Scholar

Pelegrin, P., and Surprenant, A. (2006). Pannexin-1 mediates large pore formation and interleukin-1beta release by the ATP-gated P2X7 receptor. EMBO. J. 25, 5071–5082. doi: 10.1038/sj.emboj.7601378

PubMed Abstract | Full Text | CrossRef Full Text | Google Scholar

Proulx, A. A., Lin, Z. X., and Naus, C. C. (1997). Transfection of rhabdomyosarcoma cells with connexin43 induces myogenic differentiation. Cell Growth Differ. 8, 533–540.

PubMed Abstract | Full Text | Google Scholar

Riquelme, M. A., Cea, L. A., Vega, J. L., Boric, M. P., Monyer, H., Bennett, M. V., et al. (2013). The extracellular ATP required for potentiation of the adult skeletal muscle contraction is released through pannexin 1 based channels. Neuropharmacology 75, 594–603. doi: 10.1016/j.neuropharm.2013.03.022

PubMed Abstract | Full Text | CrossRef Full Text

Ryten, M., Dunn, P. M., Neary, J. T., and Burnstock, G. (2002). ATP regulates the differentiation of mammalian skeletal muscle by activation of a P2X5 receptor on satellite cells. J. Cell. Biol. 158, 345–355. doi: 10.1083/jcb.200202025

PubMed Abstract | Full Text | CrossRef Full Text | Google Scholar

Sáez, J. C., and Leybaert, L. (2014). Hunting for hemichannels. FEBS Lett. 588, 1205–1211. doi: 10.1016/j.febslet.2014.03.004

PubMed Abstract | Full Text | CrossRef Full Text

Sáez, J. C., Schalper, K. A., Retamal, M. A., Orellana, J. A., Shoji, K. F., and Bennett, M. V. L. (2010). Cell membrane permeabilization via connexin-hemichannels in living and dying cells. Exp. Cell. Res. 316, 2377–2389. doi: 10.1016/j.yexcr.2010.05.026

PubMed Abstract | Full Text | CrossRef Full Text | Google Scholar

Sandona, D., Gastaldello, S., Martinello, T., and Betto, R. (2004). Characterization of the ATP-hydrolysing activity of alpha-sarcoglycan. Biochem. J. 381, 105–112. doi: 10.1042/BJ20031644

PubMed Abstract | Full Text | CrossRef Full Text | Google Scholar

Schalper, K. A., Lee, S. C., Altenberg, G. A., Nathanson, M. H., and Sáez, J. C. (2010). Connexin 43 is a pH-gated plasma membrane calcium channel. Am. J. Physiol. 299, C1504–C1515. doi: 10.1152/ajpcell.00015.2010

CrossRef Full Text

Schalper, K. A., Palacios-Prado, N., Orellana, J. A., and Sáez, J. C. (2008a). Currently used methods for identification and characterization of hemichannels. Cell. Commun. Adhes. 15, 207–218. doi: 10.1080/15419060802014198

PubMed Abstract | Full Text | CrossRef Full Text | Google Scholar

Schalper, K. A., Palacios-Prado, N., Retamal, M. A., Shoji, K. F., Martínez, A. D., and Sáez, J. C. (2008b). Connexin hemichannel composition determines the FGF-1-induced membrane permeability and free [Ca2+]i responses. Mol. Biol. Cell. 19, 3501–3513. doi: 10.1091/mbc.E07-12-1240

PubMed Abstract | Full Text | CrossRef Full Text | Google Scholar

Shoji, K. F., Sáez, P. J., Harcha, P. A., Aguila, H. L., and Sáez, J. C. (2014). Pannexin1 channels act downstream of P2X 7 receptors in ATP-induced murine T-cell death. Channels 8, 142–156. doi: 10.4161/chan.28122

PubMed Abstract | Full Text | CrossRef Full Text | Google Scholar

Vanden Abeele, F., Bidaux, G., Gordienko, D., Beck, B., Panchin, Y. V., Baranova, A. V., et al. (2006). Functional implications of calcium permeability of the channel formed by pannexin 1. J. Cell. Biol. 174, 535–546. doi: 10.1083/jcb.200601115

PubMed Abstract | Full Text | CrossRef Full Text | Google Scholar

Yamanouchi, K., Yada, K., Ishiguro, N., and Nishihara, M. (2007). 18α-Glycyrrhetinic acid induces phenotypic changes of skeletal muscle cells to enter adipogenesis. Cell. Physiol. Biochem. 20, 781–790. doi: 10.1159/000110438

PubMed Abstract | Full Text | CrossRef Full Text | Google Scholar

Yoshida, N., Yoshida, S., Koishi, K., Masuda, K., and Nabeshima, Y. (1998). Cell heterogeneity upon myogenic differentiation: down-regulation of MyoD and Myf-5 generates ‘reserve cells.’ J. Cell. Sci. 111, 769–779.

PubMed Abstract | Full Text | Google Scholar

Keywords: calcium signal, membrane permeability, MyoD, ATP, purinergic receptors, pannexons, myogenesis

Citation: Riquelme MA, Cea LA, Vega JL, Puebla C, Vargas AA, Shoji KF, Subiabre M and Sáez JC (2015) Pannexin channels mediate the acquisition of myogenic commitment in C2C12 reserve cells promoted by P2 receptor activation. Front. Cell Dev. Biol. 3:25. doi: 10.3389/fcell.2015.00025

Received: 12 March 2015; Accepted: 17 April 2015;
Published: 06 May 2015.

Edited by:

Ali Mobasheri, University of Surrey, UK

Reviewed by:

John Cuppoletti, University of Cincinnati, USA
Luis A. Pardo, Max-Planck-Institute of Experimental Medicine, Germany

Copyright © 2015 Riquelme, Cea, Vega, Puebla, Vargas, Shoji, Subiabre and Sáez. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

*Correspondence: Juan C. Sáez, Departamento de Fisiología, Pontificia Universidad Católica de Chile, Alameda 340, Santiago 8331010, Chile,